The First International Conference on Energy Storage Materials (ICEnSM 2017) was held in Shenzhen, the innovative city of China, on 18-21 November 2017. ICEnSM is a unique conference series initiated by the editors of a new Journal, Energy Storage Materials, published by Elsevier (https://www.journals.elsevier.com/energy-storage-materials), and Tsinghua-Berkeley Shenzhen Institute, co-founded by Tsinghua University and University of California at Berkeley.
This conference featured world-class plenary speakers, keynote speakers, and oral/poster presentations.
Energy Storage Materials was requesting written nominations from the international community for its 2017 Energy Storage Materials Award. The purpose of this award is to recognize an outstanding scientist in the field of energy storage and conversion materials and devices who has made significant contribution and whose work shows significant innovation in the field. The award was presented at this Conference, and the winner will be asked to give a plenary lecture at this conference and to write a paper related to his/her lecture for Energy Storage Materials. In addition, the Best Paper Award, the Most Cited Paper Award, and the Excellent Reviewer Awards in 2016 was conferred at the conference as well.
Professor Yury Gogotsi from Drexel University, USA, has won the 2017 Energy Storage Materials Award, which is awarded by the journal Energy Storage Materials. The Award was presented to Professor Gogotsi at the ICEnSM 2017 (2017 International Conference on Energy Storage Materials) on November 21, 2017.
The award, which is sponsored by Elsevier, gives special recognition to a person who has accomplished outstanding achievements in energy storage materials and devices. At the 2017 International Conference on Energy Storage Materials Professor Yury Gogotsi also gave a Keyneote lecture on Multidimensional Materials and Electrode Architectures for High-Rate Hybrid (Faradic+Capacitive) Energy Storage.
Professor Yury Gogotsi is recognized as one of the leaders in materials for electrochemical capacitors. His seminal work on carbon nanomaterials helped to better understand the mechanisms of capacitive energy storage. He introduced new materials to the field, such as carbon onions, and invented new technologies, such as electrochemical flow capacitors. Professor Gogotsi's recent work has concentrated on development of a new family of two-dimensional transition metal carbides and nitrides (MXenes), which he and his colleagues at Drexel University discovered in 2011. He is the author of over 500 of refereed journal papers and co-inventor of more than 60 inventions with patents issued or filed. He has an H-index of 92/109 (Web of Science/Google Scholar) and was recognized as a Highly Cited Researcher by Thomson-Reuters/Clarivate Analytics in 2014-2017. Dr. Gogotsi is Charles T. and Ruth M. Bach Professor, Distinguished University Professor and Director of the A.J. Drexel Nanomaterials Institute at Drexel University. He is also a Distinguished Foreign Professor at Jilin University, China.
Source: http://www.icensm.org/
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Our team was very delighted to take part in International Symposium "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene event in Europe this year! 
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.